Director and officer changes: A 20-year review

Gain visibility into corporate leadership stability with our comprehensive 20-year review. This report analyzes director and officer departure trends across public companies, offering critical intelligence on how organizations are navigating executive transitions and board composition in a changing economic landscape. 

Explore the factors driving leadership turnover, from mergers and acquisitions to evolving industry pressures. With deep dives into specific roles like CFOs and in-house counsel, as well as industry-specific analysis including life sciences, this report provides the benchmarks you need to assess governance risks and strategic continuity.

Download the full report for actionable data. 

• Rising departure rates: The percentage of companies experiencing a director departure reached 37% in 2024, continuing a steady upward trend over the last decade. 
• M&A impact: Mergers and acquisitions remain the leading cause of director departures, accounting for 31% of disclosed reasons in 2024. 
• Life sciences volatility: The life sciences industry is seeing heightened turnover, accounting for 17% of all director departures in 2024 despite being a smaller sector by volume. 
• C-suite transitions: CFOs continue to experience the highest turnover among officer positions, with internal position changes cited as the primary driver for 46% of officer moves.